Mega Genomics Limited (HKG:6667)

Mega Genomics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,628	2,505	2,449	3,110	-	-
Market Cap Growth	-21.01%	2.28%	-21.25%	-	-	-
Enterprise Value	1,169	2,003	1,995	2,686	-	-
Last Close Price	7.26	10.98	10.30	13.00	-	-
PE Ratio	40.04	52.26	74.01	-	-	-
Forward PE	-	9.77	9.77	14.29	-	-
PS Ratio	10.75	14.33	14.69	18.88	-	-
PB Ratio	2.43	3.83	3.45	4.45	-	-
P/TBV Ratio	2.43	3.83	3.45	4.46	-	-
P/FCF Ratio	36.57	41.74	17.39	-	-	-
P/OCF Ratio	36.35	41.19	13.58	-	-	-
EV/Sales Ratio	7.72	11.46	11.97	16.31	-	-
EV/EBITDA Ratio	20.58	32.88	51.79	-	-	-
EV/EBIT Ratio	28.80	39.11	67.80	-	-	-
EV/FCF Ratio	26.24	33.37	14.17	-	-	-
Debt / Equity Ratio	0.07	0.06	0.08	0.02	0.02	0.13
Debt / EBITDA Ratio	0.77	0.55	1.17	-	0.09	0.19
Debt / FCF Ratio	0.98	0.61	0.38	-	0.44	0.22
Net Debt / Equity Ratio	-0.69	-0.75	-0.74	-0.64	-0.65	-1.09
Net Debt / EBITDA Ratio	-8.94	-8.01	-13.66	24.73	-3.85	-1.65
Net Debt / FCF Ratio	-10.32	-8.13	-3.74	33.36	-17.04	-1.88
Asset Turnover	0.18	0.21	0.20	0.20	0.39	0.57
Inventory Turnover	8.65	9.95	15.92	18.85	22.54	21.06
Quick Ratio	14.45	6.43	5.85	7.37	9.55	1.32
Current Ratio	15.18	6.90	6.09	7.62	9.82	1.37
Return on Equity (ROE)	5.55%	7.15%	4.76%	-2.69%	18.15%	91.08%
Return on Assets (ROA)	3.05%	3.92%	2.22%	-2.06%	11.08%	18.78%
Return on Invested Capital (ROIC)	15.59%	25.02%	11.45%	-10.52%	78.45%	-
Return on Capital Employed (ROCE)	5.70%	7.40%	3.90%	-3.90%	15.50%	56.40%
Earnings Yield	2.38%	1.91%	1.35%	-0.64%	-	-
FCF Yield	2.73%	2.40%	5.75%	-0.43%	-	-
Buyback Yield / Dilution	0.61%	2.05%	-2.65%	-62.09%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.